[
  {
    "ts": null,
    "headline": "Coloplast Still Pricey Even As A High-Quality Med-Tech Growth Name",
    "summary": "Analysis of Coloplast's growth potential and concerns for Q1'25, including margin misses and slow share growth in the U.S.",
    "url": "https://finnhub.io/api/news?id=8ea794789bdb318199c57c0264ecd61c49edde9daa210b9ea114364f044e7d3d",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736437454,
      "headline": "Coloplast Still Pricey Even As A High-Quality Med-Tech Growth Name",
      "id": 132352206,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2156349876/image_2156349876.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Analysis of Coloplast's growth potential and concerns for Q1'25, including margin misses and slow share growth in the U.S.",
      "url": "https://finnhub.io/api/news?id=8ea794789bdb318199c57c0264ecd61c49edde9daa210b9ea114364f044e7d3d"
    }
  },
  {
    "ts": null,
    "headline": "AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines",
    "summary": "ANGO registers overall strong top-line results on a pro-forma basis in second-quarter fiscal 2025, driven by strength in the Med Tech business.",
    "url": "https://finnhub.io/api/news?id=02f3d7fc5dc5df3e7d6692098e9c5670294473ea96ad6e84ebc15b113d1345d2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736434080,
      "headline": "AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines",
      "id": 132350133,
      "image": "https://media.zenfs.com/en/zacks.com/32e3eb8c0cc46c163964cde251fb4426",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "ANGO registers overall strong top-line results on a pro-forma basis in second-quarter fiscal 2025, driven by strength in the Med Tech business.",
      "url": "https://finnhub.io/api/news?id=02f3d7fc5dc5df3e7d6692098e9c5670294473ea96ad6e84ebc15b113d1345d2"
    }
  },
  {
    "ts": null,
    "headline": "J&J Pauses Sales of Atrial Fibrillation Device, Stock Down",
    "summary": "J&J's MedTech unit pauses all cases of the Varipulse PFA system as part of an external evaluation. Stock dips.",
    "url": "https://finnhub.io/api/news?id=dafcbc1711f31e1526350b7a6afdcf3e0fe9d2fe856f8c8baebde1ffe781afba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736429460,
      "headline": "J&J Pauses Sales of Atrial Fibrillation Device, Stock Down",
      "id": 132347873,
      "image": "https://media.zenfs.com/en/zacks.com/955c0f2ed0992898cedf76a9efa5b1f2",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "J&J's MedTech unit pauses all cases of the Varipulse PFA system as part of an external evaluation. Stock dips.",
      "url": "https://finnhub.io/api/news?id=dafcbc1711f31e1526350b7a6afdcf3e0fe9d2fe856f8c8baebde1ffe781afba"
    }
  },
  {
    "ts": null,
    "headline": "Here's Why You Should Add Glaukos Stock to Your Portfolio Now",
    "summary": "GKOS continues to benefit from robust product demand and expansion in new markets. A strong development pipeline raises optimism.",
    "url": "https://finnhub.io/api/news?id=73562e8b76723f1fd1de05f0429b806a5cbd13b6c39c68f38e938942fa134f0b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736426580,
      "headline": "Here's Why You Should Add Glaukos Stock to Your Portfolio Now",
      "id": 132347382,
      "image": "https://media.zenfs.com/en/zacks.com/83114bcf5a91754ed7ae3f6080390cd9",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "GKOS continues to benefit from robust product demand and expansion in new markets. A strong development pipeline raises optimism.",
      "url": "https://finnhub.io/api/news?id=73562e8b76723f1fd1de05f0429b806a5cbd13b6c39c68f38e938942fa134f0b"
    }
  },
  {
    "ts": null,
    "headline": "BSX Stock Rises Following Bolt Medical Acquisition Deal Announcement",
    "summary": "Boston Scientific inks a new agreement to acquire Bolt Medical, developer of Bolt IVL, for approximately $443 million.",
    "url": "https://finnhub.io/api/news?id=337c4730cbe5d2219464fe44487773523752863aa9393c8f2dd1e4a5eb5f249f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736426580,
      "headline": "BSX Stock Rises Following Bolt Medical Acquisition Deal Announcement",
      "id": 132347875,
      "image": "https://media.zenfs.com/en/zacks.com/98f062077b0e287fed47c16e0521fc3d",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific inks a new agreement to acquire Bolt Medical, developer of Bolt IVL, for approximately $443 million.",
      "url": "https://finnhub.io/api/news?id=337c4730cbe5d2219464fe44487773523752863aa9393c8f2dd1e4a5eb5f249f"
    }
  },
  {
    "ts": null,
    "headline": "Are Boston Scientific Corporation (NYSE:BSX) Investors Paying Above The Intrinsic Value?",
    "summary": "Key Insights The projected fair value for Boston Scientific is US$75.65 based on 2 Stage Free Cash Flow to Equity...",
    "url": "https://finnhub.io/api/news?id=d7c65d139fcfad4fe33927b3ea1067b78bbba8a3cf876099d16cd5d128044e55",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736420437,
      "headline": "Are Boston Scientific Corporation (NYSE:BSX) Investors Paying Above The Intrinsic Value?",
      "id": 132347880,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/983f2bdfe32b19227b1d118c45bf4f09",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Key Insights The projected fair value for Boston Scientific is US$75.65 based on 2 Stage Free Cash Flow to Equity...",
      "url": "https://finnhub.io/api/news?id=d7c65d139fcfad4fe33927b3ea1067b78bbba8a3cf876099d16cd5d128044e55"
    }
  },
  {
    "ts": null,
    "headline": "5 medtech trends to watch in 2025",
    "summary": "After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued success for pulsed field ablation as trends to watch this year.",
    "url": "https://finnhub.io/api/news?id=91d5f832fbfd26e55b2cb3ac54ee3aacc666422960bc0cf9bbbfcd193bfa1044",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736419920,
      "headline": "5 medtech trends to watch in 2025",
      "id": 132351668,
      "image": "https://imgproxy.divecdn.com/xK13Fjf-wxji-67Juz8yez8ElUN-nQLl92xW2dbL-84/g:ce/rs:fit:770:435/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9qcGctbWVkaXVtLWR2LXN5cy1kdjUtZmlyc3RhY2Nlc3MtMi1mdWxsc3lzdGVtLXd0LTAyMjAyNF9xVTJVb055LmpwZw==.webp",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "After a busy 2024, experts called out competition in soft tissue robotics, uncertainty from a Trump White House and continued success for pulsed field ablation as trends to watch this year.",
      "url": "https://finnhub.io/api/news?id=91d5f832fbfd26e55b2cb3ac54ee3aacc666422960bc0cf9bbbfcd193bfa1044"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific to acquire remaining ownership stake in Bolt Medical for $664m",
    "summary": "Bolt Medical has developed an intravascular lithotripsy laser-based platform.",
    "url": "https://finnhub.io/api/news?id=f985f8fc9b86bcc7fd3fd74842a25dc8fed43d6ebcf7698e9b8e752408dfc207",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736417778,
      "headline": "Boston Scientific to acquire remaining ownership stake in Bolt Medical for $664m",
      "id": 132346130,
      "image": "https://live-b2b-gdm-figaro1.pantheonsite.io/wp-content/uploads/sites/23/2025/01/Boston-Scientific-to-acquire-remaining-ownership-stake-in-Bolt-Medical-for-664m-_shutterstock_1537866851.jpg",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Bolt Medical has developed an intravascular lithotripsy laser-based platform.",
      "url": "https://finnhub.io/api/news?id=f985f8fc9b86bcc7fd3fd74842a25dc8fed43d6ebcf7698e9b8e752408dfc207"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific Completes Acquisition of Bolt Medical, Bolstering Cardiovascular Portfolio",
    "summary": "Acquisition Strengthens Boston Scientific's Position in Minimally Invasive Treatment for Coronary Artery Disease",
    "url": "https://finnhub.io/api/news?id=a7098b891e9fd6ae623f9245bf26c2515bf43d17da44de986477def676b0851f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736414968,
      "headline": "Boston Scientific Completes Acquisition of Bolt Medical, Bolstering Cardiovascular Portfolio",
      "id": 132344488,
      "image": "https://media.zenfs.com/en/us.finance.gurufocus/4bfe2ca2d44e26b781d1f53d35f5fb9b",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Acquisition Strengthens Boston Scientific's Position in Minimally Invasive Treatment for Coronary Artery Disease",
      "url": "https://finnhub.io/api/news?id=a7098b891e9fd6ae623f9245bf26c2515bf43d17da44de986477def676b0851f"
    }
  },
  {
    "ts": null,
    "headline": "Terumo's Improving Growth Outlook Is Worth More Attention",
    "summary": "Terumo's solid leadership in radial access devices and expanding interventional portfolio present significant growth opportunities. See why TRUMF stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=0cea9fab3ee44dfd065db70cc56303c9c80990ed696bf600f95b7ead95b5816c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736402037,
      "headline": "Terumo's Improving Growth Outlook Is Worth More Attention",
      "id": 132345807,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1337210627/image_1337210627.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Terumo's solid leadership in radial access devices and expanding interventional portfolio present significant growth opportunities. See why TRUMF stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=0cea9fab3ee44dfd065db70cc56303c9c80990ed696bf600f95b7ead95b5816c"
    }
  },
  {
    "ts": null,
    "headline": "Here’s Why Boston Scientific Corp. (BSX) Skyrocketed Today",
    "summary": "We recently compiled a list of the 10 Firms, Predominantly Gold Miners, Lead Wednesday Rally. In this article, we are going to take a look at where Boston Scientific Corp. (NYSE:BSX) stands against the other stocks. Ten companies–predominantly gold miners–led Wednesday’s rally on Wall Street, despite the latter’s main indices closing mixed. The Dow Jones eked […]",
    "url": "https://finnhub.io/api/news?id=0aa2631dfba328e0eb0ce505c1a122635b6eb3d159b4b85603c2ca2a07352d54",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1736392876,
      "headline": "Here’s Why Boston Scientific Corp. (BSX) Skyrocketed Today",
      "id": 132344050,
      "image": "https://s.yimg.com/ny/api/res/1.2/BGLjcOQivl7Rd_HW4cGK9Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/45f2400d2f7f0dd44fd960cafcbec175",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "We recently compiled a list of the 10 Firms, Predominantly Gold Miners, Lead Wednesday Rally. In this article, we are going to take a look at where Boston Scientific Corp. (NYSE:BSX) stands against the other stocks. Ten companies–predominantly gold miners–led Wednesday’s rally on Wall Street, despite the latter’s main indices closing mixed. The Dow Jones eked […]",
      "url": "https://finnhub.io/api/news?id=0aa2631dfba328e0eb0ce505c1a122635b6eb3d159b4b85603c2ca2a07352d54"
    }
  }
]